TLOG — Tetralogic Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $24.93m
Annual cashflow statement for Tetralogic Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.9 | -16.2 | -20 | -36 | -49.7 |
| Depreciation | |||||
| Non-Cash Items | 0.318 | 0.348 | 5.67 | 6.28 | 12.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.05 | -0.231 | 1.41 | -2.81 | 1.9 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.3 | -15.9 | -12.8 | -32.4 | -34.9 |
| Capital Expenditures | -0.014 | -0.029 | -0.067 | -0.515 | -0.077 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -5.53 | 5.53 | 0 | -53.5 | 35.5 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.54 | 5.5 | -0.067 | -54 | 35.4 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.12 | 4.94 | 63.5 | 44.3 | 1.79 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.7 | -5.49 | 50.6 | -42.1 | 2.23 |